from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0946c/pgi

LFCtreatmentdescriptionclass of inhibitor

-1.234

Amikacinug/mL Amikacintranslation

-2.119

Cap5-10ug/mL Capreomycintranslation

-1.839

Rox10-50 ug/mL Roxithromycintranslation

0.022

SM2-5 ug/mL Streptomycintranslation

-1.870

Tet5-10 ug/mL Tetracyclinetranslation

-0.987

Rif0.2-5ug/mL Rifampicintranscription

-1.493

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.733

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.168

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.146

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.265

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.869

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.352

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.150

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.704

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.826

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.000

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.562

Nigericin50 uM Nigericinrespiration

1.204

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.449

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.463

menadione6-10 ug/mL Menadionerespiration

1.411

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.515

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.676

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.894

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.206

NRP_1Non-replicating persistence stage 1dosRassociated

-0.339

Amp0.2mg/mL AmpicillincellWall

0.345

Cephalexin20-100 ug/mL CephalexincellWall

-0.387

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.328

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.104

EMB10-20 ug/mL EthambutolcellWall

-0.081

Eta12-40 ug/mL EthionamidecellWall

0.254

INH0.2-0.4 ug/mL IsoniazidcellWall

0.016

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.608

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.611

BZA0.12 mg/mL BenzamidearomaticAmides

0.070

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.830

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.033

H2O24 mM hydrogen peroxideDNAdamaging

-0.719

Levo10 ug/mL LevofloxacinDNAdamaging

-0.033

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.304

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.828

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.042

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.335

Antimycin12.5-50 ug/mL Antimycin A?

-2.190

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.353

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.880

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.453

PA8240.2-2 ug/mL PA-824?

-0.730

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.506

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-0.230

mercaptoethanol2 mM 2-Mercaptoethanol?

1.446

methoxatin10-20 ug/mL Methoxatin?